Journals / Gülhane Tıp Dergisi / 2019 / Cilt: 61 - Sayı: 1

Ureaplasma SPP and mycoplasma hominis in women of reproductive age with pelvic inflammatory disease

Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In light of wide spread of strains of Ureaplasma SPP and Mycoplasma hominis, resistant to ofloxacin and macrolides, we do not suggest these antibiotics to treat the infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims:To determine the prevalence of infections with species Ureaplasma species (SPP) and Mycoplasma hominis and the antibiotic sensitivity in women of reproductive age with inflammatory diseases.
📊
Key Findings & Data:Methods:2360 samples were investigated, obtained by urethral and cervical canal scrapings of reproductive age women with pelvic inflammatory disease in the clinical diagnostic laboratory of the Regional diagnostic center of Almaty.
💡
Conclusion & Impact:In light of wide spread of strains of Ureaplasma SPP and Mycoplasma hominis, resistant to ofloxacin and macrolides, we do not suggest these antibiotics to treat the infections.
🔬Design:Research Article
📍Scope:2360 samples
⚙️Variables:Domain Parameters

Özet

Aims:To determine the prevalence of infections with species Ureaplasma species (SPP) and Mycoplasma hominis and the antibiotic sensitivity in women of reproductive age with inflammatory diseases. Methods:2360 samples were investigated, obtained by urethral and cervical canal scrapings of reproductive age women with pelvic inflammatory disease in the clinical diagnostic laboratory of the Regional diagnostic center of Almaty. The cultivation, identification and susceptibility testing of urogenital mycoplasmas and ureaplasmas to 9 antibiotics were conducted with the use of commercial kits. Results:Among 2360 tested samples total infection (isolated USPP, Mycoplasma hominis and mixed infection) was high (47.6%). The infection rate of Ureaplasma SPP was more than 30 times higher than the prevalence of Mycoplasma hominis (23.0% and 0.7%, respectively). Mixed infection was found in 23.8% of cases. Total infection of Ureaplasma SPP and Mycoplasma hominis was the highest in women aged 30-39 years (60.0%), less in women in the age group of 40-45 years (31.4%). Most active against Ureaplasma SPP and Mycoplasma hominis were tetracyclines. Indeed 94.1% of the isolated strains of Ureaplasma SPP and 98.2% of Mycoplasma hominis were sensitive to tetracycline. The doxycycline susceptibility of Ureaplasma SPP and Mycoplasma hominis was the highest (99.5% and 98.3%, respectively). Conclusions:A high level of pefloxacin sensitivity allows to recommend this antibiotic to prescribe for women with pelvic inflammatory disease. In light of wide spread of strains of Ureaplasma SPP and Mycoplasma hominis, resistant to ofloxacin and macrolides, we do not suggest these antibiotics to treat the infections.

🔖

Cite This Article

NURADILOVA, D., KALIYEVA, L., VAITKIENE, D., KALIMOLDAYEVA, S., DASIBEKOV, K., OMIOTEK, Z., MASSALSKA, T. M. (2019). Ureaplasma SPP and mycoplasma hominis in women of reproductive age with pelvic inflammatory disease. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 1, 1–5. https://ajindex.com/articles/160473

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Imudia AN, Denti L, Puscheck EE, et al. The prevalence of Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis and Neisseria gonorrhoeae infections and the rubella status of patients undergoing an initial infertility evaluation. J Assist Report Genet. 2008;25(1):43- 46
  2. Waites KB, Katz B, Schelonka RZ. Mycoplasmas and ureaplasmas as neonatal pathogens. ClinMicrobiol Rev. 2005;18(4):757-789
  3. Mutrha AP, Edwards JM. The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstetrics and gynecology clinics of North America. 2014;41(4):615-627
  4. Sobouti B, Fallah S, Mobayen M, et al. Colonization of Mycoplasma hominis and Ureaplasmaurealyticum in pregnant women and their transmission to offspring. Iran J microbial. 2014;6(4):219-224
  5. Zdrodowska-Stefanov B, Klosowska W, Ostarzewska-Ruchalska I, et al. Ureaplasma urealyticum and Mycoplasma hominis infections in women with urogenital diseases. Adv Med Sci. 2006;51:250-253
  6. Vertesamo R, Patella A, Calzolari E, et al. An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynecological outpatients, Rome, Italy. Epidemiol Infect. 2013;141(12):2650-2657
  7. Pellati D, Mylonakis I, Bertoloni G, et al. Genital tract infection and infertility. Eur J Obstet Gynecol Report Biol. 2008;140(1):3-11
  8. Gdoura R, Kchaou W, Ammar-Keskes L, et al. Assessment of Chlamydia trachomatis, Ureaplasmaurealyticum, Ureaplasma partum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl. 2008;29(2):198-206
  9. Michou IV, Constantoulakis P, Makarounis K, et al. Molecular investigation of menstrual tissue for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis collected by women with a history of infertility. J Obstet Gynecol Res. 2014;40(1):237-242
  10. Gǘnueli I, Abike F, Dǘnder I, et al. Chlamydia, Mycoplasma and Ureaplasma infections in infertile couples and effects of these infections on fertility. Ach Gynecol Obstet. 2011;283(2):379-385
  11. Miron ND, Socolov D, Mares M, et al. Bacteriological agents which play a role in the development of infertility. Acta Microbiol Immunol Hung. 2013;60(1):41-53
  12. Kong F, Ma Z, James G, et al. Molecular genotyping of human Ureaplasma species based on multiple-banded antigen (MBA) gene sequences. Int J Syst Evol Microbiol. 2000;50(5):1921-1929
  13. Xiao L, Glass JI, Paralanov V. Detection and characterization